Physician

Arash A. Horizon, M.D.

According to 2025 Medicare claims, Arash Horizon, M.D. (NPI: 1881694131) practices rheumatology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CENTER FOR RHEUMATOLOGY MEDICAL CORPORATION (NPI: 1982911160; TIN: 262900972) and primary practice location at 90048-3386. Horizon is affiliated with the VBCA NATIONAL ACO LLC (ACO ID: A5495), participating under the MSSP model.

Horizon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 603 traditional Medicare patients, billed 501,416 HCPCS/CPT codes, and received $5,718,299 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 4,391 prescription claims across 443 beneficiaries totaling $4,123,755 in drug costs, led by Stelara (Ustekinumab). 2020 DME data shows 12 claims. Open Payments data shows 2 records totaling $38. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,304,164 to $4,123,755. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	622	152,602	$2,943,523
2016	570	163,688	$3,745,793
2017	621	320,376	$4,941,109
2018	591	422,813	$5,760,564
2019	550	328,112	$6,081,842
2020	560	344,729	$6,713,727
2021	597	370,824	$6,589,436
2022	604	401,955	$4,849,300
2023	602	441,163	$5,121,056
2024	603	501,416	$5,718,299

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	451	4,763	$2,304,164
2016	431	4,583	$2,029,028
2017	431	4,524	$1,735,965
2018	412	4,346	$1,714,282
2019	402	4,262	$1,601,923
2020	412	4,654	$1,899,323
2021	442	4,254	$1,909,694
2022	449	4,333	$3,492,322
2023	418	4,281	$3,743,512
2024	443	4,391	$4,123,755

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$23,435
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	522	1,722	$10
36415	Insertion of needle into vein for collection of blood sample	537	1,813	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	522	1,731	$8
86140	Measurement c-reactive protein for detection of infection or inflammation	523	1,745	$5
85651	Red blood cell sedimentation rate, to detect inflammation, non-automated	523	1,741	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	65	2,863	$1,760,663
Rinvoq	Upadacitinib	65	1,940	$434,742
Xeljanz Xr	Tofacitinib Citrate	38	1,560	$302,939
Cosentyx Sensoready (2 Pens)	Secukinumab	25	700	$183,654
Trulicity	Dulaglutide	102	3,140	$104,229

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$38	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arash A. Horizon, M.D.?

Tedicare shows public-source Medicare data for Arash A. Horizon, M.D. (NPI 1881694131), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arash A. Horizon, M.D. have ACO affiliation data?

Arash A. Horizon, M.D. is shown with ACO affiliation data for VBCA NATIONAL ACO LLC (MSSP, ACO ID A5495).

What billing organization is linked to Arash A. Horizon, M.D.?

Arash A. Horizon, M.D. is linked to CENTER FOR RHEUMATOLOGY MEDICAL CORPORATION (billing NPI 1982911160) in the available physician profile data.

Does Arash A. Horizon, M.D. have Open Payments data?

Arash A. Horizon, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.